{"id":177108,"date":"2026-07-30T09:38:50","date_gmt":"2026-07-30T04:08:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=177108"},"modified":"2026-07-30T09:38:50","modified_gmt":"2026-07-30T04:08:50","slug":"jagsonpal-pharmaceuticals-ltd-share-price-rise-today","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/jagsonpal-pharmaceuticals-ltd-share-price-rise-today\/","title":{"rendered":"Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM): Jagsonpal Pharmaceuticals Share Price Rises 13.8% Today"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Jagsonpal Pharmaceuticals Share Price rises 13.8% to Rs 262.3, with a market cap of Rs 1,519.67 crore.<\/p>\n<p style=\"margin-top:0!important;\">Jagsonpal Pharmaceuticals Share Price has experienced a significant rise today, closing at Rs 262.3, marking a 13.8% increase from the previous close of Rs 230.5. This notable price movement places the company&#8217;s market capitalisation at Rs 1,519.67 crore.  The day&#8217;s trading saw the stock open at Rs 235.95, reaching a high of Rs 263, and a low of Rs 235.95, with a total turnover of Rs 4.15 crore. Despite <\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Jagsonpal_Pharmaceuticals_Ltd_JAGSNPHARM_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 262.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 230.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 31.8 (+13.8%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 235.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 263<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 235.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume (BSE)<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,58,245<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>BSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1,58,245<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>NSE Traded Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20,47,493<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Combined NSE + BSE Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">22,05,738<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.15 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,519.67 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/table>\n<p>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) traded at Rs 262.3. versus the previous close of Rs 230.5, a rise of 13.8%. The stock opened at Rs 235.95, reached Rs 263, touched Rs 235.95. Reported volume was 1,58,245.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Jagsonpal_Pharmaceuticals_Ltd_JAGSNPHARM_Fundamental_Analysis\"><\/span><strong>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,519.67 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.74%<\/td>\n<\/tr>\n<\/table>\n<p>Jagsonpal Pharmaceuticals Ltd. was valued at a P\/E ratio of 33.42x, a P\/B ratio of 6.4x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 15.7% and ROCE of 19.43%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<p>Per-share and shareholder-return metrics included EPS of Rs 6.9, dividend yield of 1.74%. Dividend yield is a current or historical ratio and does not guarantee future distributions.<\/p>\n<p>Jagsonpal Pharmaceuticals, with a market capitalisation of Rs 1,519.67 crore, operates within the Healthcare sector, specifically in Pharmaceuticals &#038; Drugs. The company&#8217;s P\/E ratio stands at 33.42, which is above the industry median of 26.56 but below the average of 80.39, suggesting a relatively moderate valuation. The P\/B ratio is 6.4, significantly higher than the industry median of 1.81, indicating a premium valuation. The company&#8217;s ROE is 15.7%, above the industry median of 9.91%, and ROCE is 19.43%, also above the industry median of 12.96%, reflecting efficient capital use. The EPS is Rs 6.9, and the dividend yield is 1.74%, providing a modest income stream for investors. These fundamentals suggest that while the stock is priced at a premium, it offers strong profitability metrics.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">33.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">80.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.47x to 3,385.56x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.81x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.91%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.96%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,519.67 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 146.72 crore<\/td>\n<\/tr>\n<\/table>\n<p>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a P\/E ratio of 33.42x, which is above the benchmark median of 26.56x, a difference of +25.83%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a ROE of 15.7%, which is above the benchmark median of 9.91%, a difference of +58.43%. Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a ROCE of 19.43%, which is above the benchmark median of 12.96%, a difference of +49.92%.<\/p>\n<p>Track today&#8217;s top gainers through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<p>Jagsonpal Pharmaceuticals operates in the Healthcare sector, specifically within the Pharmaceuticals &#038; Drugs industry. The sector comprises 137 companies, with Jagsonpal&#8217;s P\/E ratio of 33.42 positioned above the industry median of 26.56 but below the average of 80.39. The company&#8217;s P\/B ratio of 6.4 is significantly higher than the industry median of 1.81, indicating a premium valuation. In terms of profitability, Jagsonpal&#8217;s ROE of 15.7% and ROCE of 19.43% are both above the industry medians, highlighting its strong financial performance. The sector&#8217;s market capitalisation ranges from Rs 6.44 crore to Rs 2,856.59 crore, with Jagsonpal positioned as a small-cap player. This context underscores the company&#8217;s competitive positioning within its industry.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dcal\/dishman-carbogen-amcis-ltd-share-price-today\"><strong>Dishman Carbogen Amcis Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DCAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,856.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">30.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.89<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,686.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal\/hikal-ltd-share-price-today\"><strong>Hikal Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">HIKAL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,676.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.27<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\"><strong>Panacea Biotec Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">PANACEABIO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,540.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/solara\/solara-active-pharma-sciences-ltd-share-price-today\"><strong>Solara Active Pharma Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SOLARA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,446.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">0<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.34<\/td>\n<\/tr>\n<\/table>\n<p>Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a P\/E ratio of 33.42x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.7% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 19.43% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) has a market capitalisation of Rs 1,519.67 crore. Among the 5 peers shown, 5 have a larger market capitalisation.<\/p>\n<p>In comparison to its peers, Jagsonpal Pharmaceuticals exhibits a competitive edge in several financial metrics. While its P\/E ratio of 33.42 is higher than Dishman Carbogen Amcis Ltd. (30.28) and lower than Kwality Pharmaceuticals Ltd. (40.11), it remains within a competitive range. The company&#8217;s ROE of 15.7% surpasses that of Hikal Ltd. (15.22) and is comparable to Solara Active Pharma Sciences Ltd. (17.23). Jagsonpal&#8217;s ROCE of 19.43% is higher than Panacea Biotec Ltd. (5.36) and aligns closely with Beta Drugs Ltd. (22.17). These comparisons highlight Jagsonpal&#8217;s strong profitability and market positioning relative to its peers.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Jagsonpal_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Jagsonpal Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors are closely monitoring Jagsonpal Pharmaceuticals due to its significant price rise and strong financial metrics.<\/p>\n<ul>\n<li><strong>Price Action:<\/strong> The stock rose 13.8% today, surpassing the small-cap threshold.<\/li>\n<li><strong>Technical Position:<\/strong> Trading above key moving averages with neutral RSI.<\/li>\n<li><strong>Fundamental Context:<\/strong> Strong ROE and ROCE, premium valuation.<\/li>\n<li><strong>Sector Positioning:<\/strong> Competitive within the Pharmaceuticals &#038; Drugs industry.<\/li>\n<\/ul>\n<p>Investors should continue to monitor Jagsonpal Pharmaceuticals for further developments in its financial performance and market activity.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Jagsonpal_Pharmaceuticals\"><\/span><strong>About Jagsonpal Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jagsonpal Pharmaceuticals Ltd. is a prominent player in the Healthcare sector, focusing on the Pharmaceuticals &#038; Drugs industry. The company is engaged in the development, manufacture, and marketing of pharmaceutical products, catering to various therapeutic segments. With a strong emphasis on research and development, Jagsonpal Pharmaceuticals aims to deliver high-quality and innovative healthcare solutions. The company&#8217;s diverse product portfolio and strategic market positioning enable it to address the evolving needs of the healthcare industry. As a small-cap entity, Jagsonpal Pharmaceuticals continues to leverage its expertise to enhance its market presence and drive growth.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Jagsonpal_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Jagsonpal Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/jagsnpharm\/jagsonpal-pharmaceuticals-ltd-share-price-today\">Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top gainers lists and related market analysis.<\/p>\n<p>Investors can track Jagsonpal Pharmaceuticals Share Price on Univest for real-time updates on share price, technical indicators, fundamental ratios, and market insights. Univest provides comprehensive data, including 52-week levels and shareholding patterns, to help investors make informed decisions. Stay updated with the latest market trends and financial analysis on Univest.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Jagsonpal_Pharmaceuticals\"><\/span><strong>What is the current share price of Jagsonpal Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current share price of Jagsonpal Pharmaceuticals is Rs 262.3, reflecting a 13.8% increase from the previous close of Rs 230.5. The stock moved 13.8% during the session. The intraday range extended from Rs 235.95 to Rs 263.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Jagsonpal_Pharmaceuticals_share_price_rise_today\"><\/span><strong>How much did Jagsonpal Pharmaceuticals&#39; share price rise today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jagsonpal Pharmaceuticals&#39; share price rose by 13.8% today, closing at Rs 262.3, up from the previous close of Rs 230.5. The stock moved 13.8% during the session. The intraday range extended from Rs 235.95 to Rs 263.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Jagsonpal_Pharmaceuticals\"><\/span><strong>What is the market capitalisation of Jagsonpal Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jagsonpal Pharmaceuticals has a market capitalisation of Rs 1,519.67 crore, categorising it as a small-cap company in the Healthcare sector. The company operates in the Healthcare sector. Its P\/E ratio is 33.42x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Jagsonpal_Pharmaceuticals_compare_to_its_peers\"><\/span><strong>How does Jagsonpal Pharmaceuticals compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jagsonpal Pharmaceuticals&#39; P\/E, ROE, and ROCE are competitive within its peer group, highlighting its strong market positioning. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Jagsonpal_Pharmaceuticals\"><\/span><strong>What is the P\/E ratio of Jagsonpal Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio of Jagsonpal Pharmaceuticals is 33.42, which is above the industry median but below the average, indicating a moderate valuation. The company trades at a P\/E ratio of 33.42x.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_track_Jagsonpal_Pharmaceuticals_share_price\"><\/span><strong>How can I track Jagsonpal Pharmaceuticals&#39; share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track Jagsonpal Pharmaceuticals&#39; share price and market insights on Univest for real-time updates and comprehensive data analysis. The stock moved 13.8% during the session. The intraday range extended from Rs 235.95 to Rs 263.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jagsonpal Pharmaceuticals Ltd. Share Price rises to Rs Rs 262.3. marking a 13.8% rise today. clearing the 8% threshold for Small Cap stocks. Market cap stands<\/p>\n","protected":false},"author":29,"featured_media":177107,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-177108","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["177107"],"rank_math_title":["Jagsonpal Pharmaceuticals Share Price Rises 13.8% Today"],"rank_math_description":["Jagsonpal Pharmaceuticals Share Price rises 13.8% today, reflecting significant market activity. Explore the price action, technicals, and sector analysis."],"rank_math_focus_keyword":["Jagsonpal Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Jagsonpal_Pharmaceuticals_Ltd_JAGSNPHARM_Jagsonpal_Pharmaceuticals_Share_Price_Rises_138_Today_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/177108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=177108"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/177108\/revisions"}],"predecessor-version":[{"id":177109,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/177108\/revisions\/177109"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/177107"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=177108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=177108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=177108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}